LAKE FOREST, Ill., April 18, 2019 (GLOBE NEWSWIRE) -- Akorn, Inc. (Nasdaq:AKRX), a leading specialty generic pharmaceutical company, today announced that it received a new Abbreviated New Drug ...
SAN DIEGO--(BUSINESS WIRE)--Innovus Pharmaceuticals, Inc. ("Innovus Pharma" or the “Company”) (OTCQB Venture Market: INNV), an emerging commercial-stage pharmaceutical company that delivers safe, ...
Please provide your email address to receive an email when new articles are posted on . An exhalation delivery system that uses fluticasone propionate nasal spray reduced the symptoms of chronic ...
The FDA expanded the approval of fluticasone propionate (Xhance) nasal spray for chronic rhinosinusitis to also include treatment of adults without nasal polyps, manufacturer Optinose announced on ...
(Washington-AP) February 22, 2006 - Some people with seasonal and chronic allergies could now have a cheaper alternative to treat their symptoms. Regulators have approved the first generic version of ...
Within an hour, a single dose of a combination antihistamine that consists of loratadine and pseudoephedrine (Claritin D) delivers more than twice the rhinitis relief as a fluticasone nasal spray ...
GoodRx reports that seniors should use corticosteroid nasal sprays and avoid drowsy antihistamines like Benadryl to minimize ...
GlaxoSmithKline obtained a temporary restraining order blocking the shipment and sales of the recently FDA-approved generic competitor to its Flonase nasal spray for allergies, the Associated Press ...
GlaxoSmithKline said Friday it got a temporary restraining order blocking the shipment and sales of a recently FDA-approved generic competitor to its Flonase nasal spray. The order applies to Roxane ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results